IP Library Granted Patent US 8,829,204
Granted Patent B2
US 8,829,204 · App. 11/841,646 · Granted Sep 9, 2014

Modulators of ATP-binding cassette transporters

Inventors: Sara Hadida-Ruah (La Jolla, CA); Anna Hazlewood (San Diego, CA); Peter Grootenhuis (San Diego, CA); Fred Van Goor (San Diego, CA); Ashvani Singh (San Diego, CA); Jinglan Zhou (San Diego, CA); Jason McCartney (Cardiff by the Sea, CA)
Assignee: Vertex Pharmaceuticals Incorporated
C07D215/233C07D217/06C07D215/56C07D413/12C07D417/12C07D409/12C07D215/38C07D223/16C07D405/12C07D311/58C07D215/227C07D209/18C07D213/73C07D209/42C07D213/20C07D209/14C07D209/08C07D279/16C07D265/36C07D209/94C07D471/10C07D401/12C07C215/76C07D401/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,829,204
App. No.
11/841,646
Granted
Sep 9, 2014
Kind
B2
Abstract

The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

Claims (15)

1. A compound which is B-24

2. A process for the preparation of Compound B-24

comprising contacting 4-tert-butylaniline with N-bromosuccinimide to produce 2-bromo-4-tert-butylaniline

further contacting 2-bromo-4-tert-butylaniline with a mixture of KNO 3 and sulfuric acid to produce 2-bromo-4-tert-butyl-5-nitroaniline

contacting 2-bromo-4-tert-butyl-5-nitroaniline with trimethylsilylacetylene, Pd(PPh 3 )Cl 2 , CuI and triethylamine to produce 4-tert-butyl-5-nitro-2-((trimethylsilyl)ethynyl)aniline

contacting 4-tert-butyl-5-nitro-2-((trimethylsilyl)ethynyl)aniline with CuI to produce 5-tert-butyl-6-nitro-1H-indole

contacting 5-tert-butyl-6-nitro-1H-indole with Raney Ni in the presence of hydrogen gas to produce 6-amino-5-tert-butyl-1H-indole (B-24)

3. The process according to claim 2 , wherein the N-bromosuccinimide step further comprises a solvent.

4. The process according to claim 3 , wherein the solvent is DMF.

5. The process according to claim 2 , wherein the trimethylsilylacetylene step further comprises a solvent.

6. The process according to claim 5 , wherein the solvent is a mixture of toluene and water.

7. The process according to claim 6 , wherein the ratio of toluene to water in the mixture is about 2:1.

8. The process according to claim 2 , wherein the step to produce 5-tert-butyl-6-nitro-1H-indole further comprises a solvent.

9. The process according to claim 8 , wherein the solvent is DMF.

10. The process according to claim 9 , wherein the chemical reaction is performed at a temperature from about 120° C. to about 153° C.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 14, 2016
From: MACQUARIE US TRADING LLC
To: VERTEX PHARMACEUTICALS INCORPORATED; VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
Reel/Frame 040357/0001 →
ASSIGNEE CHANGE OF ADDRESS Recorded Feb 17, 2016
From: VERTEX PHARMACEUTICALS INCORPORATED
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 037841/0274 →
SECURITY INTEREST Recorded Jul 10, 2014
From: VERTEX PHARMACEUTICALS INCORPORATED; VERTEX PHARMACEUTICALS (SAN DIEGO) LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 033292/0311 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2012
From: HADIDA-RUAH, SARA; HAZELWOOD, ANNA; GROOTENHUIS, PETER; VAN GOOR, FREDRICK; SINGH, ASHVANI; ZHOU, JINGLAN; MCCARTNEY, JASON
To: VERTEX PHARMACEUTICALS INCORPORATED
Reel/Frame 027736/0474 →
Continuity (7)
Continuation 11165818 · Jun 24, 2005
Provisional Application 60582676 · Jun 24, 2004
Provisional Application 60630127 · Nov 22, 2004
Provisional Application 60635674 · Dec 13, 2004
Provisional Application 60658219 · Mar 3, 2005
Provisional Application 60661311 · Mar 11, 2005
Related Publication 20080071095A1 · Mar 20, 2008